Stock listing
Kane Biotech Inc.
Selected listing: KNE · TSXV · CAD · CA
Kane Biotech Inc. (TSXV:KNE), Commercial Services. Latest release Oct 7, 2026: Kane Biotech to Present Clinical Data and Showcase revyve& xAE; Product Line…
- Ticker
- TSXV:KNE
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- TSXV
- Currency
- CAD
About Kane Biotech Inc.
Kane Biotech Inc. is a public company listed under the ticker KNE on the Canadian market. Kane Biotech focuses on developing innovative solutions for the prevention and treatment of biofilm-related infections.
Latest news from Kane Biotech Inc.
Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
October 7, 2026
Kane Biotech to Host Commercial Update Webcast on September 16
September 9, 2026
Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.
September 2, 2026
Kane Biotech Announces Second Quarter 2026 Financial Results
August 27, 2026
Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium
August 25, 2026